iGMDRD81


Canonical SMILES: CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7

InChI: InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1

InChI Key: UWKQSNNFCGGAFS-XIFFEERXSA-N

Standard NameCHEMBLPubchem CIDKEGG Drug IDDRUGBANK IDDrug StatusDrug targets (TTD)Drug Type
Irinotecan plus CHK1/2 inhibitor in ATM deficient tumorCHEMBL481 CHEMBL541887 CHEMBL1200512 60838D01061DB00762CombinationDAP001339Small Molecule




Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Gene IDGene NameModel Num.
10111RAD501

Gene in drug-gene network: Network Plot

Models in Irinotecan plus CHK1/2 inhibitor in ATM deficient tumor

​​​​